— Know what they know.
Not Investment Advice
Also trades as: ZIM.DE (XETRA) · $vol 0M · ZBH.SW (SIX) · $vol 0M

ZBH NYSE

Zimmer Biomet Holdings, Inc.
1W: +3.2% 1M: -8.3% 3M: -13.6% YTD: -5.2% 1Y: -10.1% 3Y: -35.6% 5Y: -45.7%
$85.50
+0.19 (+0.22%)
 
Weekly Expected Move ±6.8%
$72 $78 $84 $89 $95
NYSE · Healthcare · Medical - Devices · Alpha Radar Sell · Power 43 · $16.5B mcap · 193M float · 1.18% daily turnover · Short 62% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.7 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 5.6%  ·  5Y Avg: 3.8%
Cost Advantage ★
68
Intangibles
44
Switching Cost
47
Network Effect
47
Scale
55
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ZBH shows a Weak competitive edge (51.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 5.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$83
Low
$93
Avg Target
$105
High
Based on 5 analysts since Apr 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 18Hold: 21Sell: 3Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$93.20
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-29 Truist Financial $101 $92 -9 +13.9% $80.80
2026-04-29 Canaccord Genuity $115 $83 -32 +0.2% $82.80
2026-04-29 Stifel Nicolaus Rick Wise $110 $105 -5 +26.8% $82.80
2026-04-29 Robert W. Baird $100 $92 -8 +11.1% $82.80
2026-04-29 Barclays Matt Miksic $100 $94 -6 +13.5% $82.80
2026-02-12 Barclays Matt Miksic $105 $100 -5 +3.4% $96.69
2026-02-11 UBS $86 $89 +3 -5.0% $93.69
2026-01-28 UBS $96 $86 -10 +0.9% $85.27
2026-01-09 Bernstein Initiated $99 +5.2% $94.08
2026-01-09 Goldman Sachs David Roman Initiated $93 -1.1% $94.08
2026-01-05 Evercore ISI $110 $120 +10 +33.3% $90.02
2025-12-16 Robert W. Baird Jeff Johnson $138 $100 -38 +8.1% $92.52
2025-11-05 Stifel Nicolaus Rick Wise $118 $110 -8 +25.1% $87.91
2025-11-05 Johnson Rice Initiated $112 +27.2% $88.05
2025-11-05 Barclays Initiated $105 +1.8% $103.18
2025-10-13 BTIG Ryan Zimmerman $126 $122 -4 +28.8% $94.71
2025-10-10 RBC Capital $112 $111 -1 +16.2% $95.53
2025-09-19 Stifel Nicolaus $115 $118 +3 +17.6% $100.36
2025-09-18 Redburn Partners Ed Ridley-Day Initiated $130 +29.7% $100.21
2025-08-08 UBS Danielle Antalffy Initiated $96 -2.0% $97.94
2025-05-06 Truist Financial Richard Newitter $117 $101 -16 +9.5% $92.27
2025-05-06 RBC Capital Shagun Singh $140 $112 -28 +21.4% $92.27
2025-05-06 Stifel Nicolaus Rick Wise $130 $115 -15 +27.1% $90.48
2025-05-05 Wells Fargo Larry Biegelsen $124 $98 -26 +8.3% $90.48
2024-10-31 Truist Financial Richard Newitter $112 $117 +5 +9.4% $106.92
2024-10-15 Oppenheimer Steven Lichtman $145 $135 -10 +28.8% $104.83
2024-10-03 BTIG Ryan Zimmerman $139 $126 -13 +19.2% $105.69
2024-10-01 Evercore ISI Vijay Kumar $170 $110 -60 +1.9% $107.95
2024-09-13 Truist Financial Richard Newitter $137 $112 -25 +6.5% $105.14
2024-09-10 Canaccord Genuity Caitlin Cronin $125 $115 -10 +9.7% $104.83
2024-08-08 Raymond James Jayson Bedford Initiated $128 +19.5% $107.09
2024-08-08 Oppenheimer Steven Lichtman $190 $145 -45 +37.0% $105.81
2024-08-07 Stifel Nicolaus Rick Wise $120 $130 +10 +20.9% $107.50
2024-07-15 Morgan Stanley Drew Ranieri $140 $120 -20 +10.4% $108.69
2024-07-01 Piper Sandler Matt O'Brien $140 $115 -25 +6.0% $108.53
2024-05-31 Piper Sandler Matthew O\'Brien $130 $140 +10 +22.3% $114.44
2024-05-30 RBC Capital Shagun Singh $141 $140 -1 +21.6% $115.14
2024-05-28 BTIG Ryan Zimmerman Initiated $139 +19.4% $116.41
2024-05-21 Argus Research David Toung Initiated $150 +26.0% $119.05
2023-02-06 Truist Financial $135 $137 +2 +6.6% $128.46
2023-02-06 Morgan Stanley $135 $140 +5 +8.7% $128.82
2023-01-08 RBC Capital $128 $141 +13 +12.2% $125.70
2023-01-06 Morgan Stanley Initiated $135 +6.5% $126.77
2022-12-20 Truist Financial $128 $135 +7 +8.1% $124.91
2022-12-12 Citigroup Initiated $130 +3.7% $125.36
2022-11-23 Wells Fargo Larry Biegelsen Initiated $124 +7.5% $115.33
2022-07-18 Stifel Nicolaus Initiated $120 +14.7% $104.62
2022-05-04 RBC Capital $125 $128 +3 +4.7% $122.20
2022-05-03 Piper Sandler Matt O'Brien $110 $130 +20 +7.1% $121.37
2022-03-02 Bank of America Securities Travis Steed Initiated $120 -1.7% $122.13

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
5
ROE
3
ROA
4
D/E
2
P/E
2
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ZBH receives an overall rating of A-. Strongest factors: DCF (5/5), ROA (4/5), P/B (4/5). Areas of concern: D/E (2/5), P/E (2/5).
Rating Change History
DateFromTo
2026-05-11 B+ A-
2026-05-06 A- B+
2026-04-29 B- A-
2026-04-28 B+ B-
2026-04-22 A- B+
2026-03-20 B+ A-
2026-03-18 A- B+
2026-03-02 B+ A-
2026-02-11 B- B+
2026-02-10 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

48 Grade A
Profitability
48
Balance Sheet
51
Earnings Quality
72
Growth
34
Value
63
Momentum
66
Safety
30
Cash Flow
78
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ZBH scores highest in Cash Flow (78/100) and lowest in Safety (30/100). An overall grade of A places ZBH among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.69
Distress Zone
Piotroski F-Score
8/9
Beneish M-Score
-2.52
Unlikely Manipulator
Ohlson O-Score
-8.76
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB-
Score: 52.6/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 2.20x
Accruals: -4.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ZBH scores 1.69, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ZBH scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ZBH's score of -2.52 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ZBH's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ZBH receives an estimated rating of BBB- (score: 52.6/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ZBH's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
21.90x
PEG
-1.50x
P/S
1.97x
P/B
1.13x
P/FCF
9.65x
P/OCF
10.58x
EV/EBITDA
11.17x
EV/Revenue
2.93x
EV/EBIT
20.45x
EV/FCF
13.42x
Earnings Yield
4.30%
FCF Yield
10.37%
Shareholder Yield
2.60%
Graham Number
$75.35
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.9x earnings, ZBH commands a growth premium. Graham's intrinsic value formula yields $75.35 per share, 13% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.843
NI / EBT
×
Interest Burden
0.750
EBT / EBIT
×
EBIT Margin
0.143
EBIT / Rev
×
Asset Turnover
0.378
Rev / Assets
×
Equity Multiplier
1.766
Assets / Equity
=
ROE
6.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ZBH's ROE of 6.0% is driven by Asset Turnover (0.378), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
22.07%
Fair P/E
52.65x
Intrinsic Value
$204.70
Price/Value
0.44x
Margin of Safety
55.83%
Premium
-55.83%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ZBH's realized 22.1% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $204.70, ZBH appears undervalued with a 56% margin of safety. The adjusted fair P/E of 52.6x compares to the current market P/E of 21.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$85.55
Median 1Y
$78.22
5th Pctile
$46.87
95th Pctile
$130.49
Ann. Volatility
30.4%
Analyst Target
$93.20
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Ivan Tornos Chairman,
President and CEO
$1,281,846 $12,000,101 $16,106,550
Jehanzeb Noor SVP,
Chief Strategy, Business Development, Innovation and Transformation Officer
$683,000 $5,100,212 $7,874,209
Suketu Upadhyay EVP
and EVP - Finance, Operations and Supply Chain
$906,780 $4,000,104 $6,211,805
Kevin Thornal Group
President, Global Businesses and the Americas
$405,385 $5,300,085 $6,210,746
Wilfred van Zuilen
Group President, EMEA
$743,149 $2,000,052 $4,139,409

CEO Pay Ratio

84:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $16,106,550
Avg Employee Cost (SGA/emp): $191,247
Employees: 17,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
17,000
0.0% YoY
Revenue / Employee
$484,206
Rev: $8,231,500,000
Profit / Employee
$41,482
NI: $705,200,000
SGA / Employee
$191,247
Avg labor cost proxy
R&D / Employee
$26,971
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 7.5% 6.7% 3.2% 1.8% 1.8% 2.2% 1.9% 3.6% 4.1% 3.8% 8.4% 7.9% 8.1% 8.8% 7.2% 7.3% 6.6% 6.5% 5.6% 6.0% 6.05%
ROA 3.7% 3.3% 1.7% 0.9% 1.0% 1.2% 1.0% 2.0% 2.3% 2.1% 4.8% 4.5% 4.7% 5.1% 4.2% 4.3% 3.8% 3.8% 3.2% 3.4% 3.42%
ROIC 5.7% 5.3% 3.9% 3.4% 3.6% 4.1% 2.9% 3.6% 3.8% 3.5% 6.9% 6.6% 6.8% 7.4% 6.2% 6.3% 5.9% 5.8% 5.3% 5.6% 5.63%
ROCE 4.8% 4.5% 3.3% 2.6% 2.7% 2.6% 3.0% 4.1% 4.5% 4.8% 6.8% 6.4% 6.6% 6.6% 6.6% 6.8% 6.5% 6.9% 5.5% 5.9% 5.87%
Gross Margin 71.9% 70.8% 67.5% 69.9% 71.3% 70.8% 71.5% 72.6% 71.9% 70.4% 72.2% 72.9% 71.5% 70.5% 71.0% 71.2% 71.5% 72.1% 64.7% 72.4% 72.39%
Operating Margin 12.7% 14.4% 3.9% 11.9% 15.8% 14.7% -1.6% 17.9% 17.6% 15.2% 18.3% 14.1% 18.1% 15.3% 19.2% 15.3% 14.4% 17.6% 12.8% 17.9% 17.88%
Net Margin 8.0% 8.6% -4.1% 0.9% 8.6% 11.6% -7.2% 12.7% 11.2% 9.3% 21.6% 9.1% 12.5% 13.7% 11.8% 9.5% 7.4% 11.5% 6.2% 11.4% 11.41%
EBITDA Margin 26.6% 28.3% 8.7% 22.6% 26.4% 27.0% 10.8% 31.0% 30.3% 29.2% 29.7% 26.7% 30.7% 29.4% 30.4% 28.8% 27.7% 31.9% 20.2% 25.8% 25.80%
FCF Margin 18.9% 20.1% 18.8% 18.4% 16.7% 16.9% 15.8% 16.1% 14.3% 11.6% 16.1% 14.4% 14.6% 16.4% 14.9% 17.5% 18.2% 20.0% 22.5% 21.8% 21.83%
OCF Margin 20.4% 21.8% 21.2% 20.8% 19.4% 19.7% 18.5% 19.1% 18.8% 17.0% 21.4% 20.2% 20.2% 20.8% 19.5% 21.5% 21.2% 21.0% 20.6% 19.9% 19.90%
ROE 3Y Avg snapshot only 7.01%
ROE 5Y Avg snapshot only 5.30%
ROA 3Y Avg snapshot only 4.02%
ROIC 3Y Avg snapshot only 4.65%
ROIC Economic snapshot only 5.51%
Cash ROA snapshot only 7.25%
Cash ROIC snapshot only 8.52%
CROIC snapshot only 9.35%
NOPAT Margin snapshot only 13.15%
Pretax Margin snapshot only 10.74%
R&D / Revenue snapshot only 5.37%
SGA / Revenue snapshot only 39.76%
SBC / Revenue snapshot only 1.13%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 34.78 35.43 62.36 120.29 94.03 77.45 113.38 59.40 59.50 48.91 24.40 27.84 22.20 20.03 23.19 24.62 21.91 24.32 25.26 23.26 21.900
P/S Ratio 4.32 4.07 3.53 3.66 3.01 3.01 3.78 3.76 4.18 3.19 3.38 3.60 2.94 2.86 2.73 2.92 2.30 2.44 2.16 2.11 1.967
P/B Ratio 2.61 2.38 1.98 2.07 1.70 1.70 2.18 2.22 2.50 1.93 2.00 2.15 1.77 1.74 1.68 1.80 1.45 1.57 1.40 1.39 1.131
P/FCF 22.80 20.22 18.78 19.94 18.05 17.79 23.92 23.37 29.21 27.38 20.96 24.97 20.14 17.41 18.35 16.67 12.67 12.23 9.64 9.65 9.645
P/OCF 21.15 18.63 16.70 17.58 15.54 15.31 20.42 19.71 22.27 18.75 15.80 17.87 14.53 13.73 13.98 13.59 10.85 11.61 10.50 10.58 10.580
EV/EBITDA 19.09 18.54 19.54 21.94 18.84 19.12 21.11 19.01 19.89 15.49 13.67 14.92 12.56 12.23 11.84 12.27 10.43 10.62 11.16 11.17 11.165
EV/Revenue 5.31 5.10 4.48 4.60 3.94 3.94 4.55 4.51 4.92 3.92 4.10 4.32 3.65 3.56 3.47 3.66 3.03 3.15 3.01 2.93 2.929
EV/EBIT 37.05 36.68 48.63 62.21 52.94 55.26 55.53 42.09 41.60 31.63 23.92 26.84 22.46 21.85 21.24 21.94 19.21 19.36 22.02 20.45 20.448
EV/FCF 28.04 25.32 23.80 25.03 23.64 23.31 28.77 28.03 34.38 33.66 25.45 29.95 25.01 21.70 23.32 20.88 16.66 15.78 13.38 13.42 13.419
Earnings Yield 2.9% 2.8% 1.6% 0.8% 1.1% 1.3% 0.9% 1.7% 1.7% 2.0% 4.1% 3.6% 4.5% 5.0% 4.3% 4.1% 4.6% 4.1% 4.0% 4.3% 4.30%
FCF Yield 4.4% 4.9% 5.3% 5.0% 5.5% 5.6% 4.2% 4.3% 3.4% 3.7% 4.8% 4.0% 5.0% 5.7% 5.5% 6.0% 7.9% 8.2% 10.4% 10.4% 10.37%
EV/OCF snapshot only 14.719
EV/Gross Profit snapshot only 4.183
Acquirers Multiple snapshot only 18.770
Shareholder Yield snapshot only 2.60%
Graham Number snapshot only $75.35
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.99 1.99 1.41 1.41 1.41 1.41 1.88 1.88 1.88 1.88 1.61 1.61 1.61 1.61 1.91 1.91 1.91 1.91 1.98 1.98 1.982
Quick Ratio 1.03 1.03 0.79 0.79 0.79 0.79 0.97 0.97 0.97 0.97 0.78 0.78 0.78 0.78 0.99 0.99 0.99 0.99 1.10 1.10 1.097
Debt/Equity 0.67 0.67 0.56 0.56 0.56 0.56 0.47 0.47 0.47 0.47 0.46 0.46 0.46 0.46 0.50 0.50 0.50 0.50 0.59 0.59 0.592
Net Debt/Equity 0.60 0.60 0.53 0.53 0.53 0.53 0.44 0.44 0.44 0.44 0.43 0.43 0.43 0.43 0.46 0.46 0.46 0.46 0.55 0.55 0.545
Debt/Assets 0.33 0.33 0.30 0.30 0.30 0.30 0.27 0.27 0.27 0.27 0.27 0.27 0.27 0.27 0.29 0.29 0.29 0.29 0.33 0.33 0.326
Debt/EBITDA 3.96 4.14 4.35 4.72 4.71 4.79 3.81 3.38 3.20 3.10 2.60 2.67 2.64 2.61 2.76 2.70 2.73 2.61 3.39 3.41 3.408
Net Debt/EBITDA 3.57 3.73 4.12 4.47 4.46 4.53 3.56 3.16 2.99 2.89 2.41 2.48 2.45 2.42 2.52 2.47 2.50 2.39 3.12 3.14 3.140
Interest Coverage 4.94 4.66 3.13 2.68 2.95 2.99 3.45 4.43 4.61 4.66 6.30 5.89 6.02 6.00 5.76 5.50 4.72 4.61 3.84 4.08 4.078
Equity Multiplier 2.00 2.00 1.85 1.85 1.85 1.85 1.75 1.75 1.75 1.75 1.72 1.72 1.72 1.72 1.71 1.71 1.71 1.71 1.82 1.82 1.817
Cash Ratio snapshot only 0.229
Debt Service Coverage snapshot only 7.468
Cash to Debt snapshot only 0.079
FCF to Debt snapshot only 0.244
Defensive Interval snapshot only 183.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.30 0.29 0.30 0.30 0.30 0.30 0.31 0.32 0.32 0.33 0.35 0.35 0.35 0.36 0.36 0.36 0.37 0.37 0.37 0.38 0.378
Inventory Turnover 0.89 0.86 0.91 0.93 0.94 0.94 0.94 0.94 0.95 0.96 0.92 0.92 0.94 0.95 0.95 0.96 0.98 0.99 1.10 1.11 1.115
Receivables Turnover 5.24 5.07 5.23 5.27 5.29 5.27 5.26 5.38 5.45 5.51 5.24 5.28 5.33 5.38 5.25 5.27 5.36 5.48 5.17 5.28 5.280
Payables Turnover 5.88 5.67 6.55 6.75 6.80 6.79 6.11 6.12 6.16 6.25 5.45 5.48 5.55 5.61 7.24 7.37 7.49 7.56 25.63 25.90 25.900
DSO 70 72 70 69 69 69 69 68 67 66 70 69 68 68 69 69 68 67 71 69 69.1 days
DIO 411 426 402 391 388 388 388 388 385 380 397 395 390 386 385 378 372 369 331 327 327.5 days
DPO 62 64 56 54 54 54 60 60 59 58 67 67 66 65 50 50 49 48 14 14 14.1 days
Cash Conversion Cycle 418 434 417 406 403 404 398 396 393 387 400 397 392 389 404 398 391 387 387 382 382.5 days
Fixed Asset Turnover snapshot only 3.810
Operating Cycle snapshot only 396.6 days
Cash Velocity snapshot only 14.207
Capital Intensity snapshot only 2.746
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 5.0% 1.0% 0.9% 4.5% -2.9% 0.2% -2.1% -0.6% 0.4% 1.8% 6.5% 4.9% 4.6% 4.3% 3.8% 3.3% 4.1% 5.5% 7.2% 9.2% 9.23%
Net Income 24.0% 6.4% 3.9% -61.7% -75.0% -66.1% -42.4% 1.1% 1.2% 70.7% 3.4% 1.1% 97.2% 1.3% -11.7% -5.2% -17.4% -25.7% -22.0% -16.7% -16.65%
EPS 23.5% 6.3% 3.9% -61.6% -74.9% -66.0% -42.6% 1.1% 1.2% 70.9% 3.5% 1.2% 1.0% 1.4% -7.9% -2.2% -14.0% -24.1% -21.3% -15.0% -14.99%
FCF 13.7% 35.3% 22.7% 46.5% -14.5% -15.7% -17.7% -13.0% -13.9% -30.0% 8.7% -6.0% 6.8% 47.1% -4.2% 25.5% 29.5% 28.4% 61.8% 36.1% 36.08%
EBITDA 1.1% 86.5% 67.4% -10.4% -26.9% -24.8% -8.0% 12.5% 18.6% 24.7% 48.5% 28.0% 22.9% 20.2% 1.4% 6.4% 4.0% 7.5% -1.5% -3.9% -3.92%
Op. Income 23.7% 115.5% 10.2% 18.9% -21.7% -16.9% -13.6% 10.7% 9.0% 11.4% 83.5% 47.4% 41.7% 39.7% 0.6% 7.9% 1.8% 6.5% -4.2% 0.0% 0.02%
OCF Growth snapshot only 1.16%
Asset Growth snapshot only 8.08%
Equity Growth snapshot only 1.91%
Debt Growth snapshot only 21.19%
Shares Change snapshot only -1.95%
Dividend Growth snapshot only -2.57%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -2.3% -3.5% -3.7% -3.2% -3.1% -3.4% -4.6% -3.0% 0.8% 1.0% 1.7% 2.9% 0.7% 2.1% 2.7% 2.5% 3.0% 3.8% 5.9% 5.8% 5.76%
Revenue 5Y -0.4% -1.3% -1.6% -1.6% -1.6% -1.6% -2.3% -2.0% -1.9% -1.7% -1.4% -1.1% -0.9% -0.9% -0.8% -0.2% 2.2% 2.5% 3.2% 4.2% 4.21%
EPS 3Y -19.3% -23.0% -41.3% 5.4% 1.4% 20.1% 3.6% 11.1% 33.0% 64.0% 56.1% 45.3% 47.8% 22.1% 22.07%
EPS 5Y 30.8% 16.8% 4.9% -15.8% -20.8% -16.2% -34.1% -23.7% -21.8% -23.3% -3.7% 20.2% 87.9% 7.6% 7.56%
Net Income 3Y -18.5% -22.4% -41.1% 6.1% 1.4% 19.3% 2.9% 9.8% 31.0% 61.3% 53.1% 42.6% 45.0% 19.2% 19.18%
Net Income 5Y 32.2% 17.7% 5.6% -15.2% -20.3% -15.7% -33.8% -23.3% -21.4% -23.0% -4.4% 19.4% 86.3% 6.0% 6.04%
EBITDA 3Y 4.2% 2.5% 15.4% 11.2% 15.0% 13.9% -11.3% 7.9% 22.2% 20.5% 31.8% 8.9% 2.1% 4.1% 11.5% 15.3% 14.9% 17.2% 14.1% 9.4% 9.39%
EBITDA 5Y 2.5% 0.3% -2.0% -4.9% -5.7% -6.0% -4.2% -1.4% -0.4% 0.2% 16.0% 14.7% 17.3% 17.2% 1.0% 11.3% 18.4% 17.7% 18.0% 5.7% 5.70%
Gross Profit 3Y -2.6% -3.6% -4.0% -3.9% -3.8% -4.2% -4.9% -3.2% 1.1% 1.4% 2.7% 4.0% 1.1% 2.5% 3.1% 3.0% 3.6% 4.7% 5.3% 5.0% 5.00%
Gross Profit 5Y 0.8% -0.4% -1.2% -1.9% -2.3% -2.2% -2.8% -2.1% -1.8% -1.6% -1.3% -1.0% -0.8% -0.8% -0.9% -0.5% 2.2% 2.7% 3.2% 4.3% 4.33%
Op. Income 3Y 9.7% 7.1% 1.9% 1.1% 3.3% -15.1% 35.6% 3.8% 24.7% 6.6% 9.0% 16.9% 20.7% 16.3% 18.4% 20.9% 16.7% 16.72%
Op. Income 5Y 5.7% 2.5% -0.5% -4.3% -4.5% -4.7% -2.8% 1.7% 2.4% 2.6% 1.1% 72.8% 1.6% 2.5% 31.7% 1.8% 15.9% 15.92%
FCF 3Y -4.7% -3.7% -5.6% -1.3% 4.6% 2.0% -2.4% -5.3% -5.7% -7.2% 3.1% 6.2% -7.7% -4.6% -5.0% 0.9% 6.0% 9.8% 19.0% 17.1% 17.10%
FCF 5Y 7.8% 3.4% -1.6% -1.7% -4.6% -5.9% -5.1% -7.2% -8.6% -12.0% -5.5% -4.7% 1.0% 1.8% -0.7% 0.0% 3.0% 8.6% 11.2% 15.4% 15.41%
OCF 3Y -4.9% -4.2% -5.0% -1.1% -1.4% -3.0% -6.8% -8.2% -1.2% 1.0% 9.5% 14.5% 0.4% 0.5% 0.0% 3.5% 6.2% 6.2% 9.7% 7.3% 7.28%
OCF 5Y 5.8% 2.3% -1.7% -1.8% -3.9% -4.9% -4.1% -5.5% -5.1% -6.9% -2.0% -0.5% 1.0% 0.5% -1.1% -1.2% 3.5% 7.0% 7.1% 10.8% 10.84%
Assets 3Y -2.1% -2.1% -0.9% -0.9% -0.9% -0.9% -5.1% -5.1% -5.1% -5.1% -4.2% -4.2% -4.2% -4.2% -3.1% -3.1% -3.1% -3.1% 3.1% 3.1% 3.11%
Assets 5Y -2.1% -2.1% -2.5% -2.5% -2.5% -2.5% -4.1% -4.1% -4.1% -4.1% -2.3% -2.3% -2.3% -2.3% -2.8% -2.8% -2.8% -2.8% -1.1% -1.1% -1.11%
Equity 3Y 1.3% 1.3% 4.0% 4.0% 4.0% 4.0% -1.0% -1.0% -1.0% -1.0% 0.8% 0.8% 0.8% 0.8% -0.5% -0.5% -0.5% -0.5% 1.9% 1.9% 1.87%
Book Value 3Y 0.3% 0.4% 3.4% 3.2% 3.3% 3.4% -1.3% -1.6% -1.5% -1.2% 0.9% 1.4% 1.5% 2.0% 1.0% 1.2% 1.5% 1.4% 3.8% 4.3% 4.34%
Dividend 3Y -0.7% -0.6% -0.2% -0.4% -0.4% -0.3% -0.1% -0.5% -0.4% -0.2% 0.1% 0.4% 0.3% 0.7% 0.6% 0.7% 0.8% 0.6% 0.9% 1.5% 1.54%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.18 0.34 0.40 0.50 0.51 0.57 0.67 0.58 0.50 0.45 0.34 0.16 0.36 0.16 0.07 0.01 0.83 0.82 0.78 0.89 0.893
Earnings Stability 0.00 0.02 0.06 0.11 0.10 0.13 0.20 0.13 0.06 0.11 0.18 0.63 0.59 0.61 0.05 0.54 0.37 0.48 0.63 0.44 0.440
Margin Stability 0.97 0.98 0.98 0.99 0.99 0.99 0.98 0.98 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.986
Rev. Growth Consistency 0.50 0.50 0.50 0.50 0.00 1.00 0.00 0.00 0.50 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.95 0.98 0.93 0.90 0.91 0.93 0.933
Earnings Smoothness 0.00 0.11 0.00 0.01 0.46 0.30 0.25 0.48 0.00 0.27 0.35 0.22 0.88 0.95 0.81 0.71 0.75 0.82 0.818
ROE Trend 0.09 0.08 -0.01 -0.02 -0.02 -0.01 0.01 0.01 -0.00 -0.01 0.06 0.05 0.05 0.06 0.02 0.02 0.01 0.00 -0.02 -0.02 -0.015
Gross Margin Trend -0.00 -0.00 -0.00 -0.01 -0.01 -0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 -0.01 -0.01 -0.00 -0.02 -0.01 -0.014
FCF Margin Trend 0.04 0.05 0.04 0.03 -0.02 -0.01 -0.01 0.00 -0.04 -0.07 -0.01 -0.03 -0.01 0.02 -0.01 0.02 0.04 0.06 0.07 0.06 0.059
Sustainable Growth Rate 5.8% 5.0% 1.6% 0.1% 0.2% 0.6% 0.2% 2.0% 2.5% 2.2% 6.7% 6.2% 6.5% 7.2% 5.7% 5.8% 5.1% 4.9% 4.1% 4.5% 4.54%
Internal Growth Rate 3.0% 2.6% 0.8% 0.1% 0.1% 0.3% 0.1% 1.1% 1.4% 1.2% 4.0% 3.7% 3.9% 4.3% 3.4% 3.5% 3.0% 3.0% 2.4% 2.6% 2.64%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.64 1.90 3.73 6.84 6.05 5.06 5.55 3.01 2.67 2.61 1.54 1.56 1.53 1.46 1.66 1.81 2.02 2.09 2.41 2.20 2.198
FCF/OCF 0.93 0.92 0.89 0.88 0.86 0.86 0.85 0.84 0.76 0.68 0.75 0.72 0.72 0.79 0.76 0.82 0.86 0.95 1.09 1.10 1.097
FCF/Net Income snapshot only 2.411
OCF/EBITDA snapshot only 0.759
CapEx/Revenue 1.5% 1.7% 2.3% 2.5% 2.7% 2.7% 2.7% 3.0% 4.5% 5.4% 5.3% 5.7% 5.6% 4.4% 4.6% 4.0% 3.1% 1.1% 1.8% 1.9% 1.93%
CapEx/Depreciation snapshot only 0.162
Accruals Ratio -0.02 -0.03 -0.05 -0.05 -0.05 -0.05 -0.05 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02 -0.02 -0.03 -0.03 -0.04 -0.04 -0.04 -0.04 -0.041
Sloan Accruals snapshot only -0.031
Cash Flow Adequacy snapshot only 4.761
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.6% 0.7% 0.8% 0.8% 0.9% 0.9% 0.8% 0.8% 0.7% 0.9% 0.8% 0.7% 0.9% 0.9% 0.9% 0.9% 1.1% 1.0% 1.1% 1.1% 1.12%
Dividend/Share $0.95 $0.95 $0.96 $0.95 $0.95 $0.96 $0.96 $0.96 $0.96 $0.96 $0.96 $0.97 $0.96 $0.98 $0.98 $0.97 $0.97 $0.96 $0.96 $0.97 $0.96
Payout Ratio 21.7% 24.4% 49.8% 92.1% 87.5% 72.3% 86.9% 44.8% 39.8% 42.4% 19.6% 20.7% 20.0% 18.3% 21.7% 21.3% 23.4% 23.7% 27.0% 24.9% 24.88%
FCF Payout Ratio 14.3% 13.9% 15.0% 15.3% 16.8% 16.6% 18.3% 17.6% 19.5% 23.7% 16.9% 18.6% 18.1% 15.9% 17.2% 14.4% 13.5% 11.9% 10.3% 10.3% 10.32%
Total Payout Ratio 21.7% 24.4% 49.8% 92.1% 87.5% 72.3% 86.9% 1.0% 95.6% 1.0% 87.2% 76.6% 81.1% 1.3% 1.2% 1.3% 1.3% 32.7% 62.4% 60.4% 60.38%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0
Chowder Number 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 -0.00 -0.01 -0.02 -0.02 -0.02 -0.03 -0.02 -0.02 -0.015
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.0% 0.9% 1.2% 2.8% 2.0% 2.8% 5.6% 4.1% 4.4% 5.0% 0.4% 1.4% 1.5% 1.53%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.0% 0.9% 1.2% 2.8% 2.0% 2.8% 5.6% 4.1% 4.4% 5.0% 0.4% 1.4% 1.4% 1.45%
Total Shareholder Return 0.6% 0.7% 0.8% 0.8% 0.9% 0.9% 0.8% 1.8% 1.6% 2.1% 3.6% 2.8% 3.7% 6.5% 5.1% 5.2% 6.1% 1.3% 2.5% 2.5% 2.52%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.09 1.05 0.90 0.66 0.65 0.82 0.57 0.76 0.76 0.67 0.96 0.97 0.98 1.05 0.87 0.87 0.85 0.79 0.85 0.84 0.843
Interest Burden (EBT/EBIT) 0.80 0.79 0.68 0.63 0.66 0.67 0.71 0.77 0.78 0.79 0.84 0.83 0.83 0.83 0.83 0.82 0.79 0.78 0.74 0.75 0.750
EBIT Margin 0.14 0.14 0.09 0.07 0.07 0.07 0.08 0.11 0.12 0.12 0.17 0.16 0.16 0.16 0.16 0.17 0.16 0.16 0.14 0.14 0.143
Asset Turnover 0.30 0.29 0.30 0.30 0.30 0.30 0.31 0.32 0.32 0.33 0.35 0.35 0.35 0.36 0.36 0.36 0.37 0.37 0.37 0.38 0.378
Equity Multiplier 2.00 2.00 1.93 1.93 1.93 1.93 1.80 1.80 1.80 1.80 1.74 1.74 1.74 1.74 1.72 1.72 1.72 1.72 1.77 1.77 1.766
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $4.35 $3.89 $1.92 $1.04 $1.09 $1.32 $1.10 $2.14 $2.41 $2.26 $4.91 $4.67 $4.83 $5.34 $4.52 $4.57 $4.15 $4.05 $3.56 $3.89 $3.89
Book Value/Share $57.87 $57.90 $60.61 $60.26 $60.20 $60.20 $57.29 $57.13 $57.27 $57.24 $59.83 $60.53 $60.47 $61.48 $62.37 $62.43 $62.87 $62.72 $64.14 $64.89 $75.58
Tangible Book/Share $-19.57 $-19.58 $-8.58 $-8.53 $-8.52 $-8.52 $-7.74 $-7.72 $-7.74 $-7.73 $-5.73 $-5.79 $-5.79 $-5.88 $-5.41 $-5.42 $-5.45 $-5.44 $-9.89 $-10.00 $-10.00
Revenue/Share $35.02 $33.88 $33.93 $34.03 $34.09 $34.01 $33.08 $33.78 $34.28 $34.66 $35.45 $36.14 $36.46 $37.42 $38.41 $38.55 $39.50 $40.30 $41.55 $42.95 $43.12
FCF/Share $6.63 $6.82 $6.38 $6.25 $5.69 $5.75 $5.23 $5.43 $4.91 $4.03 $5.71 $5.21 $5.33 $6.14 $5.72 $6.75 $7.18 $8.05 $9.33 $9.37 $9.41
OCF/Share $7.15 $7.40 $7.18 $7.09 $6.60 $6.69 $6.12 $6.44 $6.43 $5.89 $7.58 $7.28 $7.38 $7.79 $7.50 $8.28 $8.39 $8.48 $8.57 $8.55 $8.58
Cash/Share $3.81 $3.81 $1.81 $1.80 $1.80 $1.80 $1.79 $1.79 $1.79 $1.79 $1.99 $2.02 $2.01 $2.05 $2.63 $2.63 $2.65 $2.64 $2.99 $3.02 $2.18
EBITDA/Share $9.74 $9.31 $7.78 $7.13 $7.14 $7.02 $7.12 $8.01 $8.48 $8.76 $10.64 $10.46 $10.60 $10.90 $11.26 $11.50 $11.47 $11.96 $11.19 $11.27 $11.27
Debt/Share $38.57 $38.59 $33.84 $33.64 $33.61 $33.61 $27.15 $27.07 $27.14 $27.13 $27.65 $27.97 $27.95 $28.41 $31.04 $31.07 $31.29 $31.21 $37.96 $38.40 $38.40
Net Debt/Share $34.76 $34.78 $32.03 $31.85 $31.82 $31.82 $25.36 $25.29 $25.35 $25.34 $25.66 $25.96 $25.93 $26.37 $28.41 $28.44 $28.64 $28.57 $34.97 $35.38 $35.38
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.691
Altman Z-Prime snapshot only 2.861
Piotroski F-Score 7 7 6 5 4 5 6 7 8 7 8 8 7 8 6 6 6 7 7 8 8
Beneish M-Score -2.45 -2.55 -2.83 -2.84 -2.84 -2.83 -2.65 -2.65 -2.63 -2.60 -2.56 -2.56 -2.55 -2.55 -2.58 -2.61 -2.65 -2.67 -2.48 -2.52 -2.523
Ohlson O-Score snapshot only -8.765
Net-Net WC snapshot only $-26.89
EVA snapshot only $-857776979.29
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB-
Credit Score 56.15 54.64 46.80 48.00 44.93 45.34 61.20 60.46 66.78 59.77 67.38 70.44 66.63 66.81 66.89 67.98 63.97 63.84 52.78 52.56 52.560
Credit Grade snapshot only 10
Credit Trend snapshot only -15.421
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 49
Sector Credit Rank snapshot only 45

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms